FinscoFinsco

Agilon Health (US.AGL)

Capital Allocation Audit · Period: 2019 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.AGL · YoY: 2026 Q1 vs 2025 Q1

MetricValueYoY
FCF Conversion86.8%↓
ROE27.0%↑
Cash Conversion48.5%↑
D/E Ratio0.18↓
Gross Margin4.6%↑
US.AGL (Agilon Health) | YoY: 2026 Q1 vs 2025 Q1


Metric           Value  YoY
---------------------------
FCF Conversion   86.8%    ↓
ROE              27.0%    ↑
Cash Conversion  48.5%    ↑
D/E Ratio         0.18    ↓
Gross Margin      4.6%    ↑
Key Metrics
US.AGL (Agilon Health) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY
---------------------------
FCF Conversion 86.8% ↓
ROE 27.0% ↑
Cash Conversion 48.5% ↑
D/E Ratio 0.18 ↓
Gross Margin 4.6% ↑

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies